MacroGenics to Present at Wedbush PacGrow Healthcare Conference
10 August 2018 - 8:00AM
MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage
biopharmaceutical company focused on discovering and developing
innovative monoclonal antibody-based therapeutics for the treatment
of cancer, today announced that the Company's management will
provide a corporate overview presentation at the 2018 Wedbush
PacGrow Healthcare Conference in New York on Tuesday, August 14,
2018 at 10:20 am (ET).
A webcast of the conference presentation may be accessed under
"Events & Presentations" in the Investor Relations section of
MacroGenics' website at http://ir.macrogenics.com/events.cfm. The
Company will maintain an archived replay of this webcast on its
website for 30 days after the conference.
About MacroGenics, Inc.
MacroGenics is a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal
antibody-based therapeutics for the treatment of cancer. The
Company generates its pipeline of product candidates primarily from
its proprietary suite of next-generation antibody-based technology
platforms, which have applicability across broad therapeutic
domains. The combination of MacroGenics' technology platforms and
protein engineering expertise has allowed the Company to generate
promising product candidates and enter into several strategic
collaborations with global pharmaceutical and biotechnology
companies. For more information, please see the Company's website
at www.macrogenics.com. MacroGenics, the MacroGenics logo and DART
are trademarks or registered trademarks of MacroGenics, Inc.
###
Contacts:
Jim Karrels, Senior Vice President, CFO
MacroGenics, Inc.
1-301-251-5172, info@macrogenics.com
Karen Sharma, Senior Vice President
MacDougall Biomedical Communications
1-781-235-3060, ksharma@macbiocom.com
MacroGenics (NASDAQ:MGNX)
Historical Stock Chart
From Apr 2024 to May 2024
MacroGenics (NASDAQ:MGNX)
Historical Stock Chart
From May 2023 to May 2024